Natus Medical Incorporated, a leading provider of medical device solutions, announced that it has entered into a definitive agreement to be acquired by an affiliate of ArchiMed (ArchiMed), a leading investment firm focused exclusively on the healthcare industry for approximately $1.2 billion.
Under the terms of the agreement, Natus shareholders will receive $33.50 in cash for each share of Natus common stock, representing a 29% premium to the closing price of the company
